Approved Drug Clears Out Toxic Proteins in a Common Hemoglobin Disorder (2 of 3) (IMAGE)

American Association for the Advancement of Science (AAAS)

Approved Drug Clears Out Toxic Proteins in a Common Hemoglobin Disorder (2 of 3)

Caption

Mitchell Weiss, MD, PhD, St. Jude Children's Research Hospital Arthur Nienhuis Endowed Chair in Hematology. This material relates to a paper that appeared in the Aug. 21, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by C. Lechauve at St. Jude Children's Research Hospital in Memphis, TN; and colleagues was titled, "The autophagy-activating kinase ULK1 mediates clearance of free α-globin in β-thalassemia."

Credit

St. Jude Children's Research Hospital

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.